Preventing hospitalizations for COPD exacerbation: Early pulmonary rehabilitation?

Respirology

Volumn 16, Issue 4, 2011, Pages 579-580

  Bourbeau, Jean ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

chronic care; chronic obstructive pulmonary disease; hospitalization; pulmonary rehabilitation; self management

Indexed keywords

CHINA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; EDITORIAL; EVIDENCE BASED PRACTICE; HEALTH CARE SYSTEM; HEALTH PROGRAM; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; PREVALENCE; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUALITY OF LIFE;

CHINA; DISEASE PROGRESSION; FEMALE; HOSPITALIZATION; HUMANS; MALE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 79955409000     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.01956.x     Document Type: Editorial

References (20)

1. Zhong N, Wang C, Yao W, et al,. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am. J. Respir. Crit. Care Med. 2007; 176: 753-60. (Pubitemid 47598476)
2. Rodriguez-Roisin R,. Toward a consensus definition for COPD exacerbations. Chest 2000; 117 (5 Suppl. 2): 398S-401S. (Pubitemid 30314474)
3. Wedzicha JA, Seemungal TA,. COPD exacerbations: defining their cause and prevention. Lancet 2007; 370: 786-96. (Pubitemid 47320802)
4. Anzueto A, Sethi S, Martinez FJ,. Exacerbations of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2007; 4: 554-64. (Pubitemid 47547851)
5. Chapman KR, Mannino DM, Soriano JB, et al,. Epidemiology and costs of chronic obstructive pulmonary disease. Eur. Respir. J. 2006; 27: 188-207. (Pubitemid 43092683)
6. Life and Breath: Respiratory Disease in Canada. COPD Facts and Figures. Public Health Agency of Canada, 2007: 51-62.
7. Aaron SD, Vandemheen KL, Fergusson D, et al,. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann. Intern. Med. 2007; 146: 545-55. (Pubitemid 351650535)
8. Calverley PM, Anderson JA, Celli B, et al,. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 2007; 356: 775-89. (Pubitemid 46294610)
9. Tashkin DP, Celli B, Senn S, et al,. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med. 2008; 359: 1543-54.
10. Wedzicha JA, Calverley PM, Seemungal TA, et al,. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am. J. Respir. Crit. Care Med. 2008; 177: 19-26.
11. Welte T, Miravitlles M, Hernandez P, et al,. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2009; 180: 741-50.
12. Lacasse Y, Wong E, Guyatt GH, et al,. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996; 348: 1115-19. (Pubitemid 26358610)
13. Lacasse Y, Goldstein R, Lasserson TJ, et al,. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2006; (4): CD003793.
14. Ries AL, Bauldoff GS, Carlin BW, et al,. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 2007; 131 (5 Suppl): 4S-42S. (Pubitemid 46744215)
15. Ko FW, Dai DL, Ngai J,. Effect of early pulmonary rehabilitation on healthcare utilization and health status in patients hospitalized with acute exacerbations of COPD. Respirology 2011; 16: 617-24.
16. Bourbeau J, Julien M, Maltais F, et al,. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch. Intern. Med. 2003; 163: 585-91. (Pubitemid 36314346)
17. Casas A, Troosters T, Garcia-Aymerich J, et al,. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur. Respir. J. 2006; 28: 123-30. (Pubitemid 44914269)
18. Rea H, McAuley S, Stewart A, et al,. A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease. Intern. Med. J. 2004; 34: 608-14. (Pubitemid 39587142)
19. Rice KL, Dewan N, Bloomfield HE, et al,. Disease Management Program for Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial. Am. J. Respir. Crit. Care Med. 2010; 182: 890-6.
20. Nici L, Donner C, Wouters E, et al,. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2006; 173: 1390-413. (Pubitemid 43900715)